Niels F Jensen
Overview
Explore the profile of Niels F Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensen N, Stenvang J, Beck M, Hanakova B, Belling K, Do K, et al.
Mol Oncol
. 2015 Mar;
9(6):1169-85.
PMID: 25759163
Current standard treatments for metastatic colorectal cancer (CRC) are based on combination regimens with one of the two chemotherapeutic drugs, irinotecan or oxaliplatin. However, drug resistance frequently limits the clinical...
2.
Rasmussen M, Jensen N, Tarpgaard L, Qvortrup C, Romer M, Stenvang J, et al.
Mol Oncol
. 2013 Mar;
7(3):637-46.
PMID: 23506979
The backbone of current cytotoxic treatment of metastatic colorectal cancer (mCRC) consists of a fluoropyrimidine together with either oxaliplatin (XELOX/FOLFOX) or irinotecan (XELIRI/FOLFIRI). With an overall objective response rate of...
3.
Thorsen S, Obad S, Jensen N, Stenvang J, Kauppinen S
Cancer J
. 2012 Jun;
18(3):275-84.
PMID: 22647365
MicroRNAs (miRNAs) have been uncovered as important posttranscriptional regulators of nearly every biological process in the cell. Furthermore, mounting evidence implies that miRNAs play key roles in the pathogenesis of...
4.
S Olesen M, Jensen N, Holst A, Nielsen J, Tfelt-Hansen J, Jespersen T, et al.
Can J Cardiol
. 2011 May;
27(4):523.e17-23.
PMID: 21621375
Background: The protein MOG1 is a cofactor of the cardiac sodium channel, Nav1.5. Overexpression of MOG1 in Nav1.5-expressing cells increases sodium current markedly. Mutations in the genes encoding Nav1.5 and...